June 14, 2017
Single dose Betalutin® continues to show promising efficacy and safety in recurrent indolent NHL patients
Media
June 14, 2017
GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
June 13, 2017
Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference
June 12, 2017
CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors
June 11, 2017
BONESUPPORT™ announces initial public offering on Nasdaq Stockholm and a related prospectus
June 09, 2017
Nordic Nanovector to be included in Oslo Børs OBX Index
June 09, 2017
Targovax ASA – Information on the subsequent offering – Key date information
June 09, 2017
Wilson Therapeutics Receives US Orphan Drug Designation for WTX101 for the Treatment of ALS
June 08, 2017
TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
June 08, 2017
Wilson Therapeutics presents Phase 2 data for WTX101 at MDS meeting
